These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 36773572)

  • 21. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor-associated Macrophage: 
Emerging Targets for Modulating the Tumor Microenvironment].
    Zhou Y; Ren D; Bi H; Yi B; Zhang C; Wang H; Sun J
    Zhongguo Fei Ai Za Zhi; 2024 Mar; 27(3):231-240. PubMed ID: 38590197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy.
    Lin X; Fang Y; Jin X; Zhang M; Shi K
    ACS Appl Bio Mater; 2021 Aug; 4(8):5871-5896. PubMed ID: 35006894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
    Liu H; Yao M; Ren J
    Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15.
    Liu Y; Chen X; Xu Y; Yang T; Wang H; Wang Z; Hu Z; Chen L; Zhang Z; Wu Y
    J Mol Med (Berl); 2024 Jan; 102(1):81-94. PubMed ID: 37987774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
    He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
    Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
    [No Abstract]   [Full Text] [Related]  

  • 29. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles.
    Chong L; Jiang YW; Wang D; Chang P; Xu K; Li J
    J Nanobiotechnology; 2023 Oct; 21(1):401. PubMed ID: 37907987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
    Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
    Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages.
    Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H
    Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
    Hou S; Zhao Y; Chen J; Lin Y; Qi X
    J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAM-targeted reeducation for enhanced cancer immunotherapy: Mechanism and recent progress.
    Shen X; Zhou S; Yang Y; Hong T; Xiang Z; Zhao J; Zhu C; Zeng L; Zhang L
    Front Oncol; 2022; 12():1034842. PubMed ID: 36419877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage Polarization Contributes to the Anti-Tumoral Efficacy of Mesoporous Nanovectors Loaded with Albumin-Bound Paclitaxel.
    Leonard F; Curtis LT; Ware MJ; Nosrat T; Liu X; Yokoi K; Frieboes HB; Godin B
    Front Immunol; 2017; 8():693. PubMed ID: 28670313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy.
    Liang C; Zhang Y; Wang S; Jiao W; Guo J; Zhang N; Liu X
    J Mater Chem B; 2024 May; 12(20):4809-4823. PubMed ID: 38695349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy.
    Schweer D; McAtee A; Neupane K; Richards C; Ueland F; Kolesar J
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.
    Anand N; Peh KH; Kolesar JM
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.